Find out more about the new brain scan that could benefit people with Parkinson’s disease.
People with Parkinson’s disease may benefit from new brain scan
Author: Johanna Stiefler JohnsonPublished: 26 August 2021
Prep: Cook: Serves:
In a study funded by the charity Parkinson’s UK, researchers have used a new type of brain scan to uncover how an ADHD medication could benefit people with Parkinson’s disease.
Scientists from the University of Cambridge, UK, based their research on existing knowledge of atomoxetine, an ADHD drug that rebalances a chemical in the brain – which has previously shown potential benefits for impulsiveness and cognitive decline in Parkinson’s.
As part of the study, 19 participants with Parkinson’s completed tasks designed to test their thinking processes while the imaging scan examined changes in the brain. The scan showed that atomoxetine improved the participants’ impulsive behaviours.
“There has been so much progress treating the motor symptoms of Parkinson’s, but we have not seen the same gains in treating some of the hidden symptoms,” said the study’s lead researcher, Dr Claire O’Callaghan. “This is an exciting step towards individualised therapy for cognitive decline in Parkinson’s.”
For more information on the latest Parkinson’s disease research, please visit the EPDA website.
Share this story
Research offers new insights on a cause of Parkinson’s disease
Researchers in Denmark have shared insights on a cause of up to 95% of ParkREAD MORE
Vineyard pesticides may be linked to Parkinson’s disease
Exposure to pesticides used in vineyards could be linked to an increased riREAD MORE
New evidence fruit compound could support Parkinson’s disease treatment
A new study from researchers in the US and South Korea suggests farnesol, aREAD MORE